These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31239251)

  • 1. Direct Versus Calculated LDL Cholesterol and C-Reactive Protein in Cardiovascular Disease Risk Assessment in the Framingham Offspring Study.
    Ikezaki H; Fisher VA; Lim E; Ai M; Liu CT; Adrienne Cupples L; Nakajima K; Asztalos BF; Furusyo N; Schaefer EJ
    Clin Chem; 2019 Sep; 65(9):1102-1114. PubMed ID: 31239251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
    Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
    Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between the level of high-sensitivity C-reactive protein and cardiovascular risk factors in Korean adults with cardiovascular disease or diabetes mellitus: the CALLISTO study.
    Seo SM; Baek SH; Jeon HK; Kang SM; Kim DS; Kim WS; Kim HS; Rha SW; Park JS; Seong IW; Ahn YK; Yoon JH; Cha TJ
    J Atheroscler Thromb; 2013; 20(7):616-22. PubMed ID: 23676341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.
    van Deventer HE; Miller WG; Myers GL; Sakurabayashi I; Bachmann LM; Caudill SP; Dziekonski A; Edwards S; Kimberly MM; Korzun WJ; Leary ET; Nakajima K; Nakamura M; Shamburek RD; Vetrovec GW; Warnick GR; Remaley AT
    Clin Chem; 2011 Mar; 57(3):490-501. PubMed ID: 21228254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory and Cholesterol Risk in the FOURIER Trial.
    Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
    Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter evaluation of four homogenous LDL-cholesterol assays].
    Bayer P; Veinberg F; Couderc R; Cherfils C; Cambillau M; Cosson C; Fradin S; Gillery P; Steinmetz J; Legrand A; Egloff M; Beucler I
    Ann Biol Clin (Paris); 2005; 63(1):27-41. PubMed ID: 15689310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
    Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
    J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relations between fasting serum lipids and high-sensitivity C-reactive protein level in Chengdu residents].
    Shu Y; He S; Chen XP; Lü ZB; Yang R; Liu K; Cui KJ; Huang DJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):125-30. PubMed ID: 22490712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.
    Matthan NR; Zhu L; Pencina M; D'Agostino RB; Schaefer EJ; Lichtenstein AH
    J Am Heart Assoc; 2013 Feb; 2(1):e005066. PubMed ID: 23525441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of very highly elevated C-reactive protein concentration with cardiovascular events and all-cause mortality.
    Hamer M; Chida Y; Stamatakis E
    Clin Chem; 2010 Jan; 56(1):132-5. PubMed ID: 19884487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.
    Hero C; Svensson AM; Gidlund P; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K
    Diabet Med; 2016 Mar; 33(3):316-23. PubMed ID: 26498834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
    Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
    Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic low-grade inflammation, lipid risk factors and mortality in functionally dependent elderly].
    Vasović O; Trifunović D; Despotovié N; Milosević DP
    Vojnosanit Pregl; 2010 Jul; 67(7):562-8. PubMed ID: 20707051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: the Suita study.
    Arai H; Kokubo Y; Watanabe M; Sawamura T; Ito Y; Minagawa A; Okamura T; Miyamato Y
    J Atheroscler Thromb; 2013; 20(2):195-203. PubMed ID: 23076217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
    Ridker PM; Rifai N; Rose L; Buring JE; Cook NR
    N Engl J Med; 2002 Nov; 347(20):1557-65. PubMed ID: 12432042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study.
    Januzzi JL; Lyass A; Liu Y; Gaggin H; Trebnick A; Maisel AS; D'Agostino RB; Wang TJ; Massaro J; Vasan RS
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1692-7. PubMed ID: 27312221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.